A randomized trial of single daily dose vancomycin and tobramycin plus oral ciprofloxacin versus standard-dose vancomycin, ceftazidime, and tobramycin in febrile neutropenic recipients of autologous peripheral blood progenitor cell transplants

Robin K. Avery, Morton P. Goldman, Brad Pohlman, David L. Longworth, Zoraida Mendez, Michael S. Lauer, Pam Mason, Sherif B. Mossad, Karim A. Adal, Steven K. Schmitt, Matt Kalaycio, Steven Andresen, Mary E. Krivoy, Judith Brakeman, Brian Bolwell

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'A randomized trial of single daily dose vancomycin and tobramycin plus oral ciprofloxacin versus standard-dose vancomycin, ceftazidime, and tobramycin in febrile neutropenic recipients of autologous peripheral blood progenitor cell transplants'. Together they form a unique fingerprint.

Medicine & Life Sciences